Inactive Instrument

News Nanosphere, Inc.

Equities

US63009F2048

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Nanosphere Announces Intent to Voluntarily Delist From NASDAQ Capital Market	16-06-20	GL
Nanosphere Announces First Quarter Results	16-05-16	GL
Nanosphere’s Verigene BC-GP Decreases Patient Length of Stay	16-03-03	GL
Nanosphere Announces Fourth Quarter and Full Year 2015 Results, 2016 Guidance and Next Generation Verigene Progress	16-02-24	GL
Nanosphere to Announce Fourth Quarter Financial Results and Host Investor Call on Wednesday, February 24	16-02-11	GL
Nanosphere Announces Record Preliminary Q4 and Full Year 2015 Results	16-01-06	GL
Verigene® BC-GN Positioned to Provide Rapid Diagnosis of “Phantom Menace” Superbug	15-12-23	GL
Nanosphere, Inc. Announces Completion of $10 Million Registered Public Offering	15-12-22	GL
Nanosphere : Announces $10 Million Registered Public Offering	15-12-17	PU
Nanosphere Announces Record Q3 2015 Results	15-11-09	GL
Nanosphere to Announce Third Quarter Financial Results & Host Investor Call on Monday, November 9	15-11-02	GL
Impact of Verigene Blood Culture Tests Highlighted by Five Studies Presented at ICAAC 2015	15-09-22	GL
Nanosphere Receives FDA Clearance for First-of-Its-Kind Flexible Respiratory Pathogens Test	15-09-08	GL
Nanosphere Announces Record Q2 2015 Results	15-08-10	GL
Nanosphere Announces Amendment to $30 Million Term Loan Facility, Release of Q2 2015 Results and Conference Call and Schedules 2015 Annual Meeting of Stockholders	15-07-31	GL
New Studies Highlight Antibiotic Resistance Detection With Nanosphere's Verigene Blood Culture Tests	15-06-22	GL
Nanosphere Announces $4.4 Million at the Market Registered Direct Offering	15-06-08	GL
Eighteen New Verigene Clinical and Economic Studies Presented at CVS, ECCMID and MAD-ID 2015	15-05-27	GL
Nanosphere Announces Closing of New and Expanded Debt Facility and $4.4 Million at the Market Registered Direct Offering	15-05-15	GL
Nanosphere Announces Record Q1 2015 Results, New and Expanded Debt Facility, $4.4 Million at the Market Registered Direct Offering and Next Generation Verigene System Progress	15-05-11	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Nanosphere, Inc.

Equities

US63009F2048

Summary

Filters